- Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
You must select the acceptance of the agreement on compliance with the established restrictions.
Access to this information is limited to certain authorized persons who are resident and physically present in jurisdictions outside the United States, Canada, Australia and Japan.
We regret that, due to regulatory restrictions, we are unable to provide you with access to this section of our website.
